NCT07399964

Brief Summary

Insomnia is prevalent in adolescents. Impulsive behaviours and excessive risk-taking have been linked to the manifestation of psychopathology in youths. Previous research based on behavioural and neurophysiological measures has found that individuals with insomnia demonstrated impaired inhibitory control, which is associated with detrimental outcomes such as substance abuse and self-harm. Existing evidence has shown some positive effects of cognitive behavioural therapy for insomnia (CBT-I) on insomnia symptoms and daytime functioning in youths. Given the link between insomnia and impulsivity reported in previous research, and sleep as a highly modifiable factor, we are conducting this randomised controlled trial to examine the impact of CBT-I in improving impulsivity and risk-taking in youth with insomnia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jun 2024Dec 2026

Study Start

First participant enrolled

June 19, 2024

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

January 28, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 10, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 10, 2026

Status Verified

February 1, 2026

Enrollment Period

2.5 years

First QC Date

January 28, 2026

Last Update Submit

February 5, 2026

Conditions

Keywords

InsomniaYouthImpulsivityInhibitory Control

Outcome Measures

Primary Outcomes (1)

  • Change in Impulsivity

    Change in the degree of impulsivity is the degree will be measured by UPPS-P Impulsive Behavior Scale.

    Baseline, one week after the intervention and 6-month after the intervention

Secondary Outcomes (12)

  • Change in Insomnia Symptoms

    Baseline, one week after the intervention and 6-month after the intervention

  • Change of Sleep Diary Measure - Time in Bed (TIB)

    Baseline, one week after the intervention and 6-month after the intervention

  • Change of Sleep Diary Measure - Total Sleep Time (TST)

    Baseline, one week after the intervention and 6-month after the intervention

  • Change of Sleep Diary Measure - Sleep Onset Latency (SOL)

    Baseline, one week after the intervention and 6-month after the intervention

  • Change of Sleep Diary Measure - Sleep Efficiency (SE)

    Baseline, one week after the intervention and 6-month after the intervention

  • +7 more secondary outcomes

Study Arms (2)

CBT-I

EXPERIMENTAL

N = 62

Behavioral: Cognitive Behavioural Therapy for Insomnia

Health-related Psychoeducation control

ACTIVE COMPARATOR

N = 62

Other: Health-related Psychoeducation

Interventions

CBT-I consists of 6 weekly group sessions (90-min, 5-8 adolescents in each group) delivered in the afternoon/evening after school within a 10-week window. The intervention is structured and based on the well-established CBT elements for treating insomnia. The treatment components aim to address the behavioural, cognitive, and physiological factors perpetuating insomnia whilst considering the sleep and circadian features in adolescents and developmental context with the following key elements: psychoeducation about sleep, circadian rhythm and sleep hygiene, stimulus control, sleep restriction, relaxation training, structured worry time, cognitive restructuring (targeting sleep-related dysfunctional cognitions), and relapse prevention.

CBT-I

The active control group will receive group-based health-related psychoeducation, a format that has been adopted in the previous research, in order to provide the credibility of the intervention to the participants, and to control for the potential effects of attention and nonspecific components, e.g., receiving health-related information, expectations of benefit. It will also consist of 6 weekly sessions which contain education on general well-being, diet, and exercise/activity.

Health-related Psychoeducation control

Eligibility Criteria

Age12 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Chinese aged 12-24 years old
  • Written informed consent of participation in the study is given by the participant and his/her parent or guardian (for those aged under 18)
  • Willing to comply with the study protocol
  • Meeting the DSM-V diagnostic criteria of insomnia disorder and with a score on Insomnia Severity Index (ISI) \>= 9 (suggested cut-off for adolescents)

You may not qualify if:

  • A current diagnosis of substance abuse or dependence; a current or past history of manic or hypomanic episode, schizophrenia spectrum disorders, neurodevelopmental disorders, organic mental disorders, or intellectual disabilities
  • Having a prominent medical condition known to interfere with sleep continuity and quality (e.g. eczema, gastro-oesophageal reflux disease)
  • Having a clinically diagnosed sleep disorder (other than insomnia disorder) that may potentially contribute to a disruption in sleep continuity and quality, such as narcolepsy, sleep-disordered breathing, and restless leg syndrome, as ascertained by the Structured Interview for Sleep Patterns and Disorders (DISP), a validated structured diagnostic interview to assess major sleep disorders according to the International Classification of Sleep Disorder (ICSD) criteria
  • Concurrent, regular use of medications(s) known to affect sleep continuity and quality including both western medications (e.g. hypnotics, steroids) and over-the-counter OTC medications (e.g. melatonin, Traditional Chinese Medicine, TCM)
  • In the opinion of the research clinician, having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt)
  • Currently receiving any psychological treatment for insomnia
  • With hearing or speech deficit
  • Night shift worker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep Research Clinic and Laboratory, Department of Psychology, The University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersImpulsive BehaviorRisk-Taking

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Central Study Contacts

Shirley Xin LI, DClinPsy, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 28, 2026

First Posted

February 10, 2026

Study Start

June 19, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 10, 2026

Record last verified: 2026-02

Locations